Intensity Therapeutics (INTS) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.58
-1.1
-0.61
-0.13

Details

Expected EPS
-1.085
Actual EPS
-0.96
Surprise EPS
0.13
Surprise Percent
+11.52%

Description

⁨Intensity Therapeutics⁩ (⁦INTS⁩) has reported earnings of ⁦-0.96⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts